Statin Therapy in the Treatment of Sepsis
NCT00676897 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 18
Last updated 2017-06-14
Summary
Simvastatin will attenutat IL-6 levels and lead to a more rapid shock reversal than placebo
Conditions
- Septic Shock
Interventions
- DRUG
-
Simvastatin
Simvastatin 40mg PO or NGT
- DRUG
-
Corn Starch
Sponsors & Collaborators
-
Beth Israel Deaconess Medical Center
lead OTHER
Principal Investigators
-
Michael W Donnino, MD · Beth Israel Deaconess Medical Center
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-02-29
- Primary Completion
- 2010-12-31
- Completion
- 2010-12-31
Countries
- United States
Study Locations
More Related Trials
-
Clinical and Economic Outcome of Simvastatin in Critically Ill Septic Patient
NCT02067949 ·Status: COMPLETED ·Phase: PHASE3
-
Phase IIb Multicenter Randomized Controlled Trial Evaluating the Efficacy of Sivelestat in Patients With Septic Coagulopathy
NCT07214103 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
ILOPROST in Septic Shock With Persistent Microperfusion Defects (I-MICRO)
NCT03788837 ·Status: COMPLETED ·Phase: PHASE3
-
The Impact of Nafamostat Mesylate on the Prognosis of Patients With Sepsis-Induced Coagulopathy Undergoing Hemofiltration
NCT06994312 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Effect of Statin Therapy on Sepsis-related Mortality in Intensive Care Unit Patients
NCT06354452 ·Status: COMPLETED
-
Prolonged Intravenous Infusion of β-lactam Antibiotics in Early Septic Patients
NCT05024565 ·Status: UNKNOWN ·Phase: NA
-
Neutrophil Elastase Inhibitor in Treatment of ARDS Patients With Mechanical Ventilation Caused by Sepsis
NCT05672472 ·Status: UNKNOWN ·Phase: NA
-
A Safety and Efficacy Study of Intravenous E5564 in Patients With Severe Sepsis
NCT00046072 ·Status: COMPLETED ·Phase: PHASE2
-
Safety, Pharmacokinetics and Pharmacodynamics of BMS-936559 in Severe Sepsis
NCT02576457 ·Status: TERMINATED ·Phase: PHASE1
-
Pilot Study of Bevacizumab (Avastin) in Patients With Septic Shock
NCT01063010 ·Status: WITHDRAWN ·Phase: NA
-
Efficacy and Safety of Drotrecogin Alfa (Activated) in Adult Patients With Septic Shock
NCT00604214 ·Status: COMPLETED ·Phase: PHASE3
-
Epirubicin for the Treatment of Sepsis & Septic Shock
NCT05033808 ·Status: RECRUITING ·Phase: PHASE2
-
Efficacy of Anisodamine Hydrobromide Combined With Low-molecular-weight Heparin in the Treatment of Patients With Sepsis
NCT05634057 ·Status: RECRUITING ·Phase: NA
-
Protective Effect of Sivelestat Sodium on ARDS in Patients With Sepsis
NCT04973670 ·Status: UNKNOWN ·Phase: PHASE3
-
A Study To Compare The Effects Of The Infusion Of A Sepsis Drug Between Healthy Adults And Adults With Damaged Livers
NCT00158769 ·Status: COMPLETED ·Phase: PHASE1
-
Treatment of Severe Infections With Mesenchymal Stem Cells
NCT02883803 ·Status: UNKNOWN ·Phase: NA
-
Co-administration of Iloprost and Eptifibatide in Septic Shock Patients
NCT02204852 ·Status: COMPLETED ·Phase: PHASE2
-
Investigation of Novel and Established Therapies in a Human Intravenous Lipopolysaccharide Model of Sepsis
NCT06626984 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Dose Exploration Clinical Trial Evaluating the Efficacy, Safety, and Pharmacokinetic Characteristics of STC314 Injection Administered Intravenously in Sepsis Patients
NCT06548854 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Safety and Efficacy of Extracorporeal Cytokine Hemoadsorption in Septic Shock in Critically Ill Cirrhotics
NCT03866083 ·Status: UNKNOWN ·Phase: NA
-
Use of Dobutamine in Patients With Sepsis and Maintained Hypoperfusion After Initial Volemic Resuscitation.
NCT05953142 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Ibuprofen in Sepsis Study
NCT00000574 ·Status: COMPLETED ·Phase: PHASE3
-
Preemptive Resuscitation for Eradication of Septic Shock
NCT01449721 ·Status: COMPLETED ·Phase: NA
-
Serum Biomarkers to Predict Response to Angiotensin II in Septic Shock
NCT05824767 ·Status: COMPLETED ·Phase: PHASE4
-
Ulinastatin Treatment in Adult Patients With Sepsis and Septic Shock in China
NCT02647554 ·Status: COMPLETED ·Phase: PHASE4